Document is current

Any future updates will be listed below

Respiratory, thoracic, and mediastinal adverse events associated with ticagrelor: A pharmacovigilance study based on FDA adverse event reporting system

Crossref DOI link: https://doi.org/10.1007/s00210-025-04428-w

Published Online: 2025-07-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark